Patient Capital Management Opportunity Equity’s Q4 2023 Investor Letter

Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” fourth quarter 2023 investor letter. During the quarter the strategy returned 17.6% net of fees compared to the S&P 500’s 11.7% return. The portfolio’s outperformance can be attributed to a three-factor model, where interaction, selection, and allocation effects all played a significant role. In addition, you can check the top 5 holdings of the fund to know its best picks in 2023.

A copy of Patient Capital Management Opportunity Equity’s Q4 2023 investor letter can be downloaded here.